Independently tested/Batch-level documentation
Retatrutide illustrative clear glass vial with Lana Peptides label

Illustrative image. Catalogue strength: 10 mg; image label may differ.

Retatrutide

Research MaterialSample Results Published

A synthetic peptide reference material studied in the published literature as a multi-receptor incretin agonist.

Material
Retatrutide
Form
Lyophilized powder
Vial quantity
10 mg · 1 vial
Batch number
LAN-RETA-2609-01
Testing status
Report published
Storage
Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Provisional retail price · CAD$90.00
Price$90.00
1

Supplied for laboratory research use only. Not for human or veterinary use.

Verification

Latest Test Results

Batch: LAN-RETA-2609-01

Identity
Retatrutide identified by HPLC-MS/MS
Quantity
9.85 mg net peptide content (10.00 mg label claim; 98.5% fill accuracy)
Purity
99.6% chromatographic purity
Additional testing
Endotoxin: below 0.11 EU/mL (kit limit: 1 EU/mL); kinetic chromogenic LAL/TAL, USP <85>.
Independent laboratory
Side-Chain Analytics Inc. / Peptide Test Canada
Testing date
September 26, 2026

Tested sample: RET-619; endotoxin sample: ENDO-RET-619. Reports: COA-2026-SC-02740 and COA-2026-SC-02740-EN. Results apply only to the samples received and tested, not other vials or an entire lot or batch. These reports do not establish sterility, safety, efficacy, regulatory compliance, or suitability for human or veterinary use.

Batch archive

Material Overview

Retatrutide (research designation LY3437943) is a synthetic peptide investigated in published research as an agonist at GIP, GLP-1 and glucagon receptors. Supplied strictly as a reference material for in-vitro laboratory research.

Research Context

Retatrutide has been described in peer-reviewed literature investigating triple incretin receptor pharmacology. Published clinical research is conducted under regulated trial conditions and is unrelated to the supply of reference material.

Storage & Handling

Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.

Molecular Information

Peptide sequence
Proprietary synthetic sequence (see supplier documentation)
Molecular formula
C221H342N46O68
Molecular weight
4731.3 g/mol
CAS number
2381089-83-2
Synonyms
LY3437943
Research classification
Single peptide reference material

Common questions about Retatrutide

What purity is Retatrutide tested to?
Our specification is Reported per batch. Each lot's sample is sent to an independent third-party laboratory, and published reports apply only to the sample tested.
How should Retatrutide be stored?
Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
What strength and form is supplied?
10 mg per vial, supplied as lyophilized powder.
Where does Retatrutide ship from?
Orders are processed and dispatched within Canada. Shipping is $22 CAD on orders under $300 and free at $300 or more.
Is Retatrutide for human use?
No. It is sold strictly for laboratory research use only and is not for human or veterinary consumption.
Retatrutide
10 mg · $90.00 CAD
1